CorMedix (CRMD) News Today → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free CRMD Stock Alerts $5.16 -0.03 (-0.58%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6 at 8:30 AM | globenewswire.comCorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathMay 28, 2024 | markets.businessinsider.comCorMedix Secures Strong Market Position with Successful DefenCath Launch and Strategic Supply AgreementsMay 28, 2024 | globenewswire.comCorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis ProviderMay 13, 2024 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call TranscriptMay 13, 2024 | marketbeat.comCorMedix's (CRMD) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $10.00 target price on shares of CorMedix in a research report on Monday.May 10, 2024 | finance.yahoo.comCorMedix Inc. (CRMD) Q1 2024 Earnings: Net Loss Widens, Misses Analyst ForecastsMay 10, 2024 | globenewswire.comCorMedix Inc. to Participate in Two Upcoming Investor ConferencesMay 9, 2024 | msn.comCRMD Stock Earnings: Cormedix Beats EPS for Q1 2024May 9, 2024 | globenewswire.comCorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 7, 2024 | marketbeat.comCorMedix (CRMD) Scheduled to Post Quarterly Earnings on ThursdayCorMedix (NASDAQ:CRMD) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 6, 2024 | globenewswire.comCorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024April 30, 2024 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Sees Significant Growth in Short InterestCorMedix Inc. (NASDAQ:CRMD - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 9,380,000 shares, a growth of 13.7% from the March 31st total of 8,250,000 shares. Based on an average daily volume of 587,000 shares, the days-to-cover ratio is presently 16.0 days.April 20, 2024 | investing.comCorMedix product 'DefenCath' gains CMS transitional payment statusApril 20, 2024 | finanznachrichten.deCorMedix, Inc.: CorMedix Inc. Announces CMS Grants TDAPA to DefenCathApril 19, 2024 | marketwatch.comCorMedix Shares Rise 6% After DefenCath Meets Payment CriteriaApril 19, 2024 | globenewswire.comCorMedix Inc. Announces CMS Grants TDAPA to DefenCathApril 16, 2024 | marketbeat.comShort Interest in CorMedix Inc. (NASDAQ:CRMD) Increases By 6.2%CorMedix Inc. (NASDAQ:CRMD - Get Free Report) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 8,250,000 shares, an increase of 6.2% from the March 15th total of 7,770,000 shares. Based on an average daily trading volume, of 443,800 shares, the days-to-cover ratio is presently 18.6 days.April 15, 2024 | investorplace.comBiotech on a Budget: 7 Stocks Under $10 With Huge PotentialApril 15, 2024 | globenewswire.comCorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)April 15, 2024 | finance.yahoo.comCRMD Apr 2024 7.000 callApril 15, 2024 | finance.yahoo.comCRMD Apr 2024 8.000 putApril 11, 2024 | finance.yahoo.comCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America ConferenceApril 11, 2024 | globenewswire.comCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America ConferenceApril 9, 2024 | marketbeat.comCorMedix (NASDAQ:CRMD) Receives Market Outperform Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $19.00 price objective on shares of CorMedix in a report on Tuesday.April 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)April 8, 2024 | globenewswire.comCorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLCApril 2, 2024 | finance.yahoo.comBreakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)March 27, 2024 | finance.yahoo.comCorMedix Inc. to Present at the Needham Annual Healthcare ConferenceMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 6.000 putMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 3.000 putMarch 16, 2024 | finance.yahoo.comCRMD Apr 2024 3.000 callMarch 15, 2024 | insidertrades.comCorMedix Inc. (NASDAQ:CRMD) CEO Joseph Todisco Purchases 13,561 SharesMarch 14, 2024 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) CEO Buys $50,718.14 in StockCorMedix Inc. (NASDAQ:CRMD - Get Free Report) CEO Joseph Todisco bought 13,561 shares of CorMedix stock in a transaction that occurred on Wednesday, March 13th. The shares were acquired at an average cost of $3.74 per share, for a total transaction of $50,718.14. Following the completion of the transaction, the chief executive officer now directly owns 352,839 shares in the company, valued at $1,319,617.86. The transaction was disclosed in a filing with the SEC, which is available at this link.March 13, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Cormedix (CRMD)March 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)March 13, 2024 | finance.yahoo.comCorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | seekingalpha.comAyr Wellness reports mixed Q4 results; initiates Q1 FY24 outlookMarch 12, 2024 | markets.businessinsider.comBuy Rating on Cormedix Amidst DefenCath Launch and Strong Financial PositioningMarch 12, 2024 | marketwatch.comCorMedix Shares Move Lower After 4Q UpdateMarch 12, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Cormedix (CRMD), PROCEPT BioRobotics (PRCT)March 12, 2024 | msn.comCorMedix (CRMD) Q4 2023 Earnings Call TranscriptMarch 12, 2024 | finance.yahoo.comCormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCathMarch 12, 2024 | finanznachrichten.deCorMedix, Inc.: CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 12, 2024 | sfgate.comCorMedix: Q4 Earnings SnapshotMarch 12, 2024 | globenewswire.comCorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 11, 2024 | benzinga.com6CRMD : Cormedix Earnings PreviewMarch 7, 2024 | marketbeat.comCorMedix (CRMD) Scheduled to Post Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing earnings before the market opens on Tuesday, March 12, Zacks reports.March 6, 2024 | globenewswire.comCorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024March 5, 2024 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Down 3.8%CorMedix (NASDAQ:CRMD) Stock Price Down 3.8%February 22, 2024 | benzinga.comCormedix Stock (NASDAQ:CRMD), Short Interest Report Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Hurry! Buy this stock before the Robinhood traders do! (Ad)Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades CRMD Media Mentions By Week CRMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.000.76▲Average Medical News Sentiment CRMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼12▲CRMD Articles Average Week Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NATR News SLDB News BDTX News AQST News SCPH News OPTN News DBVT News IFRX News CMRX News ACHL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored